By ThinkSabio #ThinkSabio Latest News
HUMA announced that the FDA has granted full approval for SYMVESS, an acellular bioengineered vessel, for use in adults as a vascular conduit in extremity arterial injuries when urgent revascularization is needed to prevent limb loss and autologous vein graft is not feasible.